利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

30 条记录 (耗时 0.043 秒)

    Extract from plant of japanese parsley family and process for producing the same
    11.
    发明申请
    Extract from plant of japanese parsley family and process for producing the same 审中-公开
    从日本欧芹系列植物提取物及其生产方法

    公开(公告)号：US20070092587A1

    公开(公告)日：2007-04-26

    申请号：US10561431

    申请日：2004-06-18

    申请人： Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Tatsuji Enoki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    发明人： Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Tatsuji Enoki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    IPC分类号： A61K36/232

    CPC分类号： A61K36/232 ,  A23L2/02 ,  A23V2002/00 ,  A23V2250/21 ,  A23V2200/328

    摘要： The present invention provides an extract obtainable by extracting a plant belonging to Umbelliferae, or a processed product thereof, with a water-containing alcohol; a process for preparing the extract; a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response and/or diabetic complications, characterized in that the therapeutic agent or prophylactic agent comprises as an effective ingredient the extract as defined above; an agent for an insulin-mimetic action, characterized in that the agent comprises as an effective ingredient the extract as defined above; a food, beverage or feed, comprising the extract as defined above; an agent for enhancing glucose uptake into a cell, characterized in that the agent comprises as an effective ingredient the extract as defined above; to an agent for inducing differentiation into an adipocyte, characterized in that the agent comprises as an effective ingredient the extract as defined above; and an inhibitory agent for aldose reductase, characterized in that the agent comprises as an effective ingredient the extract as define above.

    摘要翻译： 本发明提供通过用含水醇提取属于伞形赤霉属的植物或其加工产物而获得的提取物; 一种制备提取物的方法; 用于伴随胰岛素或胰岛素反应量和/或糖尿病并发症的异常的疾病的治疗剂或预防剂，其特征在于所述治疗剂或预防剂包含作为有效成分的上述提取物; 用于胰岛素模拟作用的药剂，其特征在于所述药剂包含如上所定义的提取物作为有效成分; 包含上述提取物的食品，饮料或饲料; 用于增强葡萄糖摄入细胞的药剂，其特征在于所述药剂包含如上所定义的提取物作为有效成分; 涉及诱导分化为脂肪细胞的药剂，其特征在于所述药剂包含如上所定义的提取物作为有效成分; 以及醛糖还原酶抑制剂，其特征在于，所述药剂含有作为有效成分的上述定义的提取物。

    Remedy
    12.
    发明申请
    Remedy 审中-公开
    补救

    公开(公告)号：US20060216362A1

    公开(公告)日：2006-09-28

    申请号：US10557184

    申请日：2004-05-14

    申请人： Tatsuji Enoki ,  Kinuko Ogawa ,  Hiromu Ohnogi ,  Nobuko Muraki ,  Yoko Kudo ,  Hiroaki Sagawa ,  Ikunoshin Kato

    发明人： Tatsuji Enoki ,  Kinuko Ogawa ,  Hiromu Ohnogi ,  Nobuko Muraki ,  Yoko Kudo ,  Hiroaki Sagawa ,  Ikunoshin Kato

    IPC分类号： A61K36/9066 ,  A61K36/886 ,  A61K36/282 ,  A61K36/28 ,  A61K36/704 ,  A61K36/185

    CPC分类号： A61K36/896 ,  A23K20/10 ,  A23L33/105 ,  A61K36/185 ,  A61K36/28 ,  A61K36/282 ,  A61K36/287 ,  A61K36/70 ,  A61K36/704 ,  A61K36/886 ,  A61K36/906 ,  A61K36/9066

    摘要： The present invention relates to a therapeutic agent and prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for an insulin-mimetic action, a food, beverage and feed for treating a preventing a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for enhancing glucose uptake into a cell, and an agent for inducing differentiation into an adipocyte, characterized in that each comprises as an effective ingredient a processed product derived from at least one plant selected from the group consisting of (a) a plant belonging to Tiliaceae, (b) a plant belonging to Zingiberaceae, (c) a plant belonging to Compositae, (d) a plant belonging to Liliaceae, and (e) a plant belonging to Polygonaceae.

    摘要翻译： 本发明涉及一种伴随胰岛素或胰岛素反应量异常的疾病的治疗剂和预防剂，用于胰岛素模拟作用的药物，用于治疗预防伴随异常的疾病的食品，饮料和饲料 一定量的胰岛素或胰岛素反应，用于增强葡萄糖摄入细胞的药剂和用于诱导分化成脂肪细胞的药剂，其特征在于每种药物包含作为有效成分的来自至少一种选自以下的植物的加工产品： （a）属于尖嘴科的植物，（b）属于姜科的植物，（c）属于菊科的植物，（d）属于百合科的植物，和（e）属于Poly科的植物。

    Chalcone compound
    14.
    发明授权
    Chalcone compound 失效
    查耳酮化合物

    公开(公告)号：US07361774B2

    公开(公告)日：2008-04-22

    申请号：US10529859

    申请日：2003-09-29

    申请人： Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Tatsuji Enoki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    发明人： Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Tatsuji Enoki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    IPC分类号： C07D311/82 ,  C07D311/00 ,  A01N43/16

    CPC分类号： C07D311/80 ,  A23K20/121 ,  A23L33/10 ,  C07D311/58

    摘要： The present invention relates to a chalcone compound represented by the following general formula: wherein R1 and R2 are taken together with the carbon atom to which they are bound, respectively, to form a hydroxydimethyl hexane ring, or where R1 is a hydroxyl group, R2 is an isohexenyl group, a derivative thereof, or a salt thereof. Also, the present invention relates to a therapeutic agent or prophylactic agent for a disease requiring neuronal protection, suppression for nitrogen monoxide (NO) production, inhibition for aldose reductase or suppression for interleukin production, and a food, beverage or feed for treatment or prevention of the above-mentioned disease, characterized in that each comprises the above-mentioned compound as an effective ingredient.

    摘要翻译： 本发明涉及由下列通式表示的查尔酮化合物：其中R 1和R 2分别与它们所连接的碳原子一起取代， 形成羟基二甲基己烷环，或其中R 1是羟基，R 2是异己烯基，其衍生物或其盐。 此外，本发明涉及需要神经元保护，抑制一氧化氮（NO）产生，抑制醛糖还原酶或抑制白介素产生的疾病的治疗剂或预防剂，以及用于治疗或预防的食品，饮料或饲料 的上述疾病，其特征在于，每种都包含上述化合物作为有效成分。

    Remedy
    17.
    发明申请
    Remedy 审中-公开
    补救

    公开(公告)号：US20060034949A1

    公开(公告)日：2006-02-16

    申请号：US10524015

    申请日：2003-08-06

    申请人： Tatsuji Enoki ,  Kinuko Ogawa ,  Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    发明人： Tatsuji Enoki ,  Kinuko Ogawa ,  Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    IPC分类号： A61K36/232

    CPC分类号： A61K36/232 ,  A23L2/52 ,  A23L33/105 ,  A23V2002/00 ,  A23V2200/328 ,  A23V2250/21

    摘要： The present invention relates to a therapeutic agent or prophylactic agent for a disease accompanying an abnormality in an amount of insulin or insulin response, an insulin-mimetic action agent, a food, beverage, or feed for treating or preventing a disease accompanying an abnormality in an amount of insulin or insulin response, an agent for enhancement of glucose uptake into a cell, and an agent for induction of an adipocyte differentiation, each comprising as an effective ingredient a processed product derived from a plant belonging to Umbelliferae.

    摘要翻译： 本发明涉及一种伴随胰岛素或胰岛素反应量异常的疾病的治疗剂或预防剂，用于治疗或预防伴随异常的疾病的胰岛素模拟作用剂，食品，饮料或饲料 一定量的胰岛素或胰岛素反应，用于增强葡萄糖摄入细胞的药剂和用于诱导脂肪细胞分化的药剂，其各自包含衍生自属于伞形属植物的植物的加工产品作为有效成分。

    Remedies
    19.
    发明申请
    Remedies 失效
    补救措施

    公开(公告)号：US20050272809A1

    公开(公告)日：2005-12-08

    申请号：US10529859

    申请日：2003-09-29

    申请人： Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Tatsuji Enoki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    发明人： Hiromu Ohnogi ,  Katsumi Sugiyama ,  Nobuko Muraki ,  Tatsuji Enoki ,  Hiroaki Sagawa ,  Ikunoshin Kato

    IPC分类号： A23K1/16 ,  A23L1/30 ,  A61P25/00 ,  A61P43/00 ,  C07D311/58 ,  C07D311/80 ,  A61K31/353 ,  C07D311/76

    CPC分类号： C07D311/80 ,  A23K20/121 ,  A23L33/10 ,  C07D311/58

    摘要： The present invention relates to a novel chalcone compound represented by the following general formula: wherein R1 and R2 are taken together with the carbon atom to which they are bound, respectively, to form a hydroxydimethyl hexane ring, or where R1 is a hydroxyl group, R2 is an isohexenyl group, a derivative thereof, or a salt thereof. Also, the present invention relates to a therapeutic agent or prophylactic agent for a disease requiring neuronal protection, suppression for nitrogen monoxide (NO) production, inhibition for aldose reductase or suppression for interleukin production, and a food, beverage or feed for treatment or prevention of the above-mentioned disease, characterized in that each comprises the above-mentioned compound as an effective ingredient.

    摘要翻译： 本发明涉及由以下通式表示的新型查耳酮化合物：其中R 1和R 2分别与它们所结合的碳原子一起连接 ，以形成羟基二甲基己烷环，或其中R 1是羟基，R 2是异己烯基，其衍生物或其盐。 此外，本发明涉及需要神经元保护，抑制一氧化氮（NO）产生，抑制醛糖还原酶或抑制白介素产生的疾病的治疗剂或预防剂，以及用于治疗或预防的食品，饮料或饲料 的上述疾病，其特征在于，每种都包含上述化合物作为有效成分。